Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.
about
Ameliorative effect of fisetin on cisplatin-induced nephrotoxicity in rats via modulation of NF-κB activation and antioxidant defenceHydroxyl radical mediates cisplatin-induced apoptosis in human hair follicle dermal papilla cells and keratinocytes through Bcl-2-dependent mechanismNew Therapeutic Concept of NAD Redox Balance for Cisplatin NephrotoxicityRole of endoplasmic reticulum stress in drug-induced toxicityMechanism of Platinum Derivatives Induced Kidney InjuryThe balance of powers: Redox regulation of fibrogenic pathways in kidney injuryElectrochemistry of nonconjugated proteins and glycoproteins. Toward sensors for biomedicine and glycomicsCurtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatmentMechanisms of Cisplatin nephrotoxicityRole of guanine-nucleotide exchange factor Epac in renal physiology and pathophysiologyProteomic candidate biomarkers of drug-induced nephrotoxicity in the ratThe restrained expression of NF-kB in renal tissue ameliorates folic acid induced acute kidney injury in miceThe Role of Hydrogen Sulfide in Renal SystemRenal drug transporters and their significance in drug-drug interactionsRole of Oxidative Stress in Drug-Induced Kidney InjuryCisplatin-induced Kidney Dysfunction and Perspectives on Improving Treatment StrategiesAttenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signalingExpression of CA125 and cisplatin susceptibility of pleural effusion-derived human lung cancer cells from a Thai patientmicroRNAs in kidneys: biogenesis, regulation, and pathophysiological rolesMetallothionein blocks oxidative DNA damage induced by acute inorganic arsenic exposureThe Cytotoxicity Mechanism of 6-Shogaol-Treated HeLa Human Cervical Cancer Cells Revealed by Label-Free Shotgun Proteomics and Bioinformatics AnalysismiR-125b transcriptionally increased by Nrf2 inhibits AhR repressor, which protects kidney from cisplatin-induced injuryMitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in miceMicrovesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injurySphingosine 1-phosphate receptor-1 enhances mitochondrial function and reduces cisplatin-induced tubule injury.Immunohistochemical localization of OCT2 in the cochlea of various species.Protection of glucagon-like peptide-1 in cisplatin-induced renal injury elucidates gut-kidney connection.Screen of FDA-approved drug library reveals compounds that protect hair cells from aminoglycosides and cisplatin.Membrane transporters as mediators of Cisplatin effects and side effects.Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions.Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models.N-acetylcysteine for the prevention of non-contrast media agent-induced kidney injury: from preclinical data to clinical evidence.Augmentation of NAD(+) by NQO1 attenuates cisplatin-mediated hearing impairment.Therapeutic drug-induced platelet apoptosis: an overlooked issue in pharmacotoxicology.Oxaliplatin-induced renal tubular vacuolization.The pseudoginsenoside F11 ameliorates cisplatin-induced nephrotoxicity without compromising its anti-tumor activity in vivo.Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells.Renalase prevents AKI independent of amine oxidase activityEffect of glutathione combined with cisplatin and oxaliplatin on the proliferation and apoptosis of lung carcinoma cell line.OMA1 mediates OPA1 proteolysis and mitochondrial fragmentation in experimental models of ischemic kidney injury.
P2860
Q21090597-49D84402-D658-4DF0-B894-56957BEB4DC9Q23921929-CE59AA17-FDCC-441E-85F5-63FE38EFC1C5Q26765483-81715012-5893-44A5-866F-A185D81D5451Q26765518-76293E04-1B57-4822-83CF-A098DA306538Q26783436-9CA7212B-8ED0-4FB1-B758-52E8C78422E7Q26786137-DDF30EB5-FD60-4604-A290-F8240385BF02Q26822552-43153634-E980-48EE-84C3-7D0898640D5EQ26823867-738F56DE-CDAD-42F7-8CD1-F6E77A7DF6ADQ26996320-53188EAB-7DC2-4E74-AE20-23485BE4929EQ27003242-E097A364-A69D-47E5-ABC2-4662C3305C5BQ27305109-7DBB5D3E-E8E0-4F11-98DF-368CCFDA541EQ27318623-9DEA2F46-D95C-45C5-B506-D90FE9BE70E6Q28066719-F911EB56-E798-4DE8-ACCF-7A600C8C5191Q28071292-C28C96D8-97A6-476C-99DE-2A9B68E5068AQ28074502-01926140-37F7-4177-98EA-A351527F54FAQ28080842-C9D423AA-52B4-4B57-AA3B-4F6D28A87039Q28385015-EB5FFA14-6E56-45BD-8891-87ED092A7B93Q28386717-3DDDE711-A64D-4966-9BFB-FFEC463C7061Q28387168-1D95AAA6-CE45-4727-B707-CFEB9CCF7E14Q28387251-F6CCC61E-2A78-4C63-AD9F-48E7FB3C5DFAQ28391923-60B7B0D1-9B3D-46B2-B375-C05DB309976BQ28395772-1CD44D21-4844-44C5-A908-126CEE134AE5Q28546437-C75C49F1-7581-419A-8855-C6DEFE818037Q28731306-6CCD358D-2776-49BF-84EE-079CD4474A30Q30359883-CD6669BD-532D-4022-A01D-3B1CD87797E5Q30368484-EE1E8CAB-6FD6-401E-8424-244364542A29Q30390165-150248E3-D80F-4FA0-9B34-A7E50CC2357AQ30446543-6FD9BAF5-58D9-422B-92D2-1D0A2C6A20ABQ30446860-142C4699-C41E-4A1E-B973-D912769814DCQ30476563-0A0C7C7D-C520-4384-A6B5-79C6FA14AE49Q30487260-DB08E08D-8184-4B77-913C-96253DBF20CFQ30603357-CBA900C4-69E2-4FE8-885F-27AC7410443CQ30669518-95784C56-E1A3-48A6-9703-F551F113FEA9Q33412254-B451FB18-02F9-4F4A-8018-13EE3D92426EQ33413828-3E7C4242-C0F6-471C-9955-8E3EB8D75F6BQ33620539-33E95DF9-0C1B-4CEB-BE6F-2605B312E793Q33655696-2E69AC95-1727-41EC-91C2-33EB6C0BB0CCQ33660611-7A22547F-7DB9-4C5B-B603-98C5F8251EC9Q33693186-BEC6BD6F-E549-440D-9F8A-9F7FE146B646Q33701546-142845D3-4273-490C-80BD-BB20DC67DE3E
P2860
Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.
@en
Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.
@nl
type
label
Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.
@en
Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.
@nl
prefLabel
Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.
@en
Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.
@nl
P356
P1433
P1476
Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.
@en
P2888
P304
P356
10.1038/SJ.KI.5002786
P407
P577
2008-02-13T00:00:00Z